These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 24266847)

  • 21. Phage Therapy: A New Horizon in the Antibacterial Treatment of Oral Pathogens.
    Shlezinger M; Khalifa L; Houri-Haddad Y; Coppenhagen-Glazer S; Resch G; Que YA; Beyth S; Dorfman E; Hazan R; Beyth N
    Curr Top Med Chem; 2017; 17(10):1199-1211. PubMed ID: 27770768
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activity of Bacteriophages in Removing Biofilms of
    Fong SA; Drilling A; Morales S; Cornet ME; Woodworth BA; Fokkens WJ; Psaltis AJ; Vreugde S; Wormald PJ
    Front Cell Infect Microbiol; 2017; 7():418. PubMed ID: 29018773
    [No Abstract]   [Full Text] [Related]  

  • 23. [Phage associated polysaccharide depolymerases - characteristics and application].
    Maszewska A
    Postepy Hig Med Dosw (Online); 2015 Jun; 69():690-702. PubMed ID: 26206986
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aminoglycosides Antagonize Bacteriophage Proliferation, Attenuating Phage Suppression of Bacterial Growth, Biofilm Formation, and Antibiotic Resistance.
    Zuo P; Yu P; Alvarez PJJ
    Appl Environ Microbiol; 2021 Jul; 87(15):e0046821. PubMed ID: 34020940
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ameliorating the antimicrobial resistance crisis: phage therapy.
    Saha D; Mukherjee R
    IUBMB Life; 2019 Jul; 71(7):781-790. PubMed ID: 30674079
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibiotic discovery: combatting bacterial resistance in cells and in biofilm communities.
    Penesyan A; Gillings M; Paulsen IT
    Molecules; 2015 Mar; 20(4):5286-98. PubMed ID: 25812150
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of polyvalent bacteriophages to combat biofilm of Proteus mirabilis causing catheter-associated urinary tract infections.
    Maszewska A; Zygmunt M; Grzejdziak I; Różalski A
    J Appl Microbiol; 2018 Nov; 125(5):1253-1265. PubMed ID: 29924909
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The interaction of phage and biofilms.
    Sutherland IW; Hughes KA; Skillman LC; Tait K
    FEMS Microbiol Lett; 2004 Mar; 232(1):1-6. PubMed ID: 15061140
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bacteriophage therapy for inhibition of multi drug-resistant uropathogenic bacteria: a narrative review.
    Chegini Z; Khoshbayan A; Vesal S; Moradabadi A; Hashemi A; Shariati A
    Ann Clin Microbiol Antimicrob; 2021 Apr; 20(1):30. PubMed ID: 33902597
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Going Viral: Emerging Opportunities for Phage-Based Bacterial Control in Water Treatment and Reuse.
    Mathieu J; Yu P; Zuo P; Da Silva MLB; Alvarez PJJ
    Acc Chem Res; 2019 Apr; 52(4):849-857. PubMed ID: 30925037
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phage Lysins for Fighting Bacterial Respiratory Infections: A New Generation of Antimicrobials.
    Vázquez R; García E; García P
    Front Immunol; 2018; 9():2252. PubMed ID: 30459750
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Back to the future: bacteriophages as promising therapeutic tools.
    Domingo-Calap P; Georgel P; Bahram S
    HLA; 2016 Mar; 87(3):133-40. PubMed ID: 26891965
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antimicrobial assessment of phage therapy using a porcine model of biofilm infection.
    Milho C; Andrade M; Vilas Boas D; Alves D; Sillankorva S
    Int J Pharm; 2019 Feb; 557():112-123. PubMed ID: 30590127
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bacteria-phage interactions in natural environments.
    Díaz-Muñoz SL; Koskella B
    Adv Appl Microbiol; 2014; 89():135-83. PubMed ID: 25131402
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Viruses versus bacteria-novel approaches to phage therapy as a tool against multidrug-resistant pathogens.
    Viertel TM; Ritter K; Horz HP
    J Antimicrob Chemother; 2014 Sep; 69(9):2326-36. PubMed ID: 24872344
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ecology of Anti-Biofilm Agents II: Bacteriophage Exploitation and Biocontrol of Biofilm Bacteria.
    Abedon ST
    Pharmaceuticals (Basel); 2015 Sep; 8(3):559-89. PubMed ID: 26371011
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting biofilms using phages and their enzymes.
    Azeredo J; García P; Drulis-Kawa Z
    Curr Opin Biotechnol; 2021 Apr; 68():251-261. PubMed ID: 33714050
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current review-The rise of bacteriophage as a unique therapeutic platform in treating peri-prosthetic joint infections.
    Akanda ZZ; Taha M; Abdelbary H
    J Orthop Res; 2018 Apr; 36(4):1051-1060. PubMed ID: 28971508
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spatial vulnerability: bacterial arrangements, microcolonies, and biofilms as responses to low rather than high phage densities.
    Abedon ST
    Viruses; 2012 May; 4(5):663-87. PubMed ID: 22754643
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Significance of Mutualistic Phages for Bacterial Ecology and Evolution.
    Obeng N; Pratama AA; Elsas JDV
    Trends Microbiol; 2016 Jun; 24(6):440-449. PubMed ID: 26826796
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.